The Penn Lyme vaccine relies on mRNA, the same approach used in the Pfizer and Moderna vaccines against COVID-19.

UW Health is looking for 75 people to test a new Lyme disease vaccine that targets more strains of the tick-borne illness ...

If this new vaccine succeeds it will be the first time in over 20 years that there’s been a human vaccine for Lyme. In order ...

A worldwide Phase 3 clinical study of a possible vaccine for Lyme disease is underway and UVM Medical Center is one of the ...

Cases of the tick-borne illness have surged in recent decades, prompting a push to develop new immunizations. A shot from Pfizer is in late clinical trials, and Penn Medicine is testing another ...

Penn Medicine researchers created an experimental mRNA vaccine that could protect against Borrelia burgdorferi, the bacteria that causes Lyme disease. The vaccine, described in Cell Press, uses the ...

There is a vaccine for the flu, there's a vaccine for polio, rabies, rubella, and the list goes on. And while vaccines often take several years to develop and get approval for, the COVID-19 ...

There is a vaccine for the flu, there's a vaccine for polio, rabies, rubella, and the list goes on. And while vaccines often take several years to develop and get approval for, the COVID-19 ...

There is a vaccine for the flu, there's a vaccine for polio, rabies, rubella, and the list goes on. And while vaccines often take several years to develop and get approval for, the COVID-19 ...

There is a vaccine for the flu, there's a vaccine for polio, rabies, rubella, and the list goes on. And while vaccines often take several years to develop and get approval for, the COVID-19 ...